References
- El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020; 69: 859–867.
- Heizer WD, Southern S, McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: A narrative review. J Am Diet Assoc. 2009; 109: 1204–1214.
- Pietrzak A, Skrzydło-Radomańska B, Mulak A. Lipiński M, Małecka-Panas E, Reguła J, Rydzewska G. Rekomendacje diagnostyczno-terapeutyczne w zespole jelita nadwrażliwego. Gastroenterology Rev. 2018; 13: 259–288.
- Cuomo R, Andreozzi P, Zito FP, Valentina Passananti V, Giovanni De Carlo G, Sarnelli G. Irritable bowel syndrome and food interaction. World J Gastroenterol. 2014; 20: 8837–8845.
- Gupta D, Ghoshal UC, Misra A, Choundhuri G, Singh K. Lactose intolerance in patients with irritable bowel syndrome from northern India: A case-control study. J Gastroenterol Hepatol. 2007; 22: 2261–2265.
- Parker TJ, Woolner JT, Prevost AT, Tuffnell Q, Shorthouse M, Hunter JO. Irritable bowel syndrome: Is the search for lactose intolerance justified? Eur J Gastroenterol Hepatol. 2001; 13: 219–225.
- Martin-Gallausiaux C, Marinelli L, Blottière HM, Larraufie P, Lapaque N. SCFA: Mechanisms and functional importance in the gut. Proc Nutr Soc. 2021; 80: 37–49.
- Hertzler SR, Savaiano DA. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr. 1996; 64: 232–236.
- Mäkivuokko HA, Saarinen MT, Ouwehand AC, Rautonen NE. Effects of lactose on colon microbial community structure and function in a four-stage semi-continuous culture system. Biosci Biotechnol Biochem. 2006; 70: 2056–2063.
- Szilagyi A, Shrier I, Heilpern D, Je J, Park S, Chong G, Lalonde C, Cote L-F, Lee B. Differential impact of lactose/lactase phenotype on colonic microflora. Can J Gastroenterol. 2010; 24: 373–379.
- Kato K, Ishida S, Tanaka M, Mitsuyama E, Xiao J-Z, Odamaki T. Association between functional lactase variants and a high abundance of Bifidobacterium in the gut of healthy Japanese people. PLoS One. 2018; 13: e0206189.
- Cano-Contreras AD, Minero Alfaro IJ, Medina López VM, Amieva Balmori M, Remes Troche JM, Espadaler Mazo J, Perez Lopez N. Efficacy of i3.1 probiotic on improvement of lactose intolerance symptoms: A randomized, placebo-controlled clinical trial. J Clin Gastroenterol. 2020; 56: 141–147.
- Halkjaer SI, Christensen AH, Lo BZS, Browne PD, Günther S, Hestbjerg Hansen LH, Petersen AM. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: Results from a randomised, double-blind placebo-controlled study. Gut. 2018; 67: 2107–2115.
- Johnsen PH, Hilpusch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, Goll R. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: A double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol. Hepatol. 2018; 3: 17–24.
- Malikowski T, Khanna S, Pardi DS. Fecal microbiota transplantation for gastrointestinal disorders. Curr. Opin. Gastroenterol. 2017; 33: 8–13.
- El-Salhy M, Hausken T, Hatlebakk JG. Increasing the dose and/or repeating faecal microbiota transplantation (FMT) increases the response in patients with irritable bowel syndrome (IBS). Nutrients. 2019; 11: 1415.
- Carroccio A, Montalto G, Cavera G, Notarbatolo A. Lactose intolerance and self-reported milk intolerance: Relationship with lactose maldigestion and nutrient intake. Lactase Deficiency Study Group. J Am Coll Nutr. 1998; 17: 631–636
- Varju P, Gede N, Szakacs Z, Hegyi P, Cazacu IM, Pécsi D, Fábián A, Szepes Z, Vincze Á, Tenk J, et al. Lactose intolerance but not lactose mal-digestion is more frequent in patients with irritable bowel syndrome than in healthy controls: A meta-analysis. Neurogastroenterol Motil. 2019; 31: e13527.
- Yang J, Deng Y, Chu H, Cong Y, Zhao J, Pohl D, Misselwitz B, Fried M, Dai N, Fox M. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013; 11: 262–268.
- Zhu Y, Zheng X, Cong Y, Chu H, Fried M, Dai N, Fox M. Bloating and distention in irritable bowel syndrome: The role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol. 2013; 108: 1516–1525.
- Vesa TH, Seppo LM, Marteau PR, Sahi T, Korpela R. Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr. 1998; 67: 710–715.
- Vernia P, Marinaro V, Argnani F, Di Camillo M, Caprilli R. Self-reported milk intolerance in irritable bowel syndrome: What should we believe? Clin Nutr. 2004; 23: 996–1000.
- Baadkar SV, Mukherjee MS, Lele SS. Study on influence of age, gender and genetic variants on lactose intolerance and its impact on milk intake in adult Asian Indians. Ann Human Biol. 2014; 41: 548–553.
- Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol Suppl. 1994; 202: 7–20.
- Bernardes-Silva CF, Prereira AC, Alves da Mota G., Krieger JE, Laudanna AA. Lactase persistence/non-persistence variants, C/T_13910 and G/A_22018, as a diagnostic tool for lactose intolerance in IBS patients. Clin Chim Acta. 2007; 386: 7–11.
- Di Stefano M, Veneto G, Malservisi S, Strocchi A, Corazza GR. Lactose malabsorption and intolerance in the elderly. Scand J Gastroenterol. 2001; 36: 1274–1278.
- Goulding A, Taylor RW, Keil D, Gold E, Lewis-Barned NJ, Williams SM. Lactose malabsorption and rate of bone loss in older women. Age Ageing. 1999; 28: 175–180.